½ÃÀ庸°í¼­
»óǰÄÚµå
1490861

¼¼°èÀÇ È¯ÀÚ Âü¿© Ç÷§Æû ¹× ¼Ö·ç¼Ç : ¿¹Ãø(-2028³â)

Global Patient Engagement Platforms and Solutions, Forecast to 2028

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Frost & Sullivan | ÆäÀÌÁö Á¤º¸: ¿µ¹® 63 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼ºÀå ±âȸ¸¦ Àâ´Â °æÀï Àü·«

¼¼°èÀÇ È¯ÀÚ Âü¿©(PE) »ê¾÷Àº Áö¼ÓÀûÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù. ȯÀÚ Á᫐ ÀÇ·á¿¡ ÁßÁ¡À» µÎ°í µðÁöÅÐ °Ç°­ ¼Ö·ç¼ÇÀ» º¸±ÞÇϰí ÀÇ·á ¼º°ú Çâ»ó¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ÀÌ ¾÷°èÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

Frost & SullivanÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®Àº ÀÌ ¿ªµ¿ÀûÀÎ ºÎ¼­¸¦ ÀÚ¼¼È÷ Á¶»çÇϰí 2028³â±îÁö ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç°æÀï ±¸µµ, ¼ºÀå Àü·«, °æÁ¦ »óȲÀ» ÆÄ¾ÇÇϰí ÀÖ½À´Ï´Ù. º¸°í¼­´Â »ý¸í°úÇÐ ¹× B2C PE ½ÃÀå, ÀÇ·á±â±â ¹× ¿þ¾î·¯ºí°ú °°Àº Ç÷§ÆûÀÇ Çϵå¿þ¾î ±¸¼º ¿ä¼Ò¸¦ Á¦¿ÜÇÕ´Ï´Ù.

¶ÇÇÑ ÃÖ´ë ¼ºÀå ±âȸ, µð½º·¦Æ¼ºê ±â¼ú, Áö¿ª µ¿Çâ, ºñÁî´Ï½º ¸ðµ¨ ºÐ¼®µµ ¼öÇàÇϰí ÀÖ½À´Ï´Ù. ÀÌ Ã¶ÀúÇÑ Á¶»ç¸¦ ÅëÇØ ÀÇ·á ÀÌÇØ°ü°èÀÚ´Â ¾÷°èÀÇ ÁøÈ­ÇÏ´Â »óȲÀ» È¿°úÀûÀ¸·Î Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á »ê¾÷ÀÌ È¯ÀÚ Áß½ÉÀÇ Äɾî¿Í µðÁöÅÐ Çõ½ÅÀ» ÇâÇØ º¯È­¸¦ °è¼ÓÇϰí ÀÖ´Â µ¿¾È, ȯÀÚ Âü¿© ½ÃÀåÀÇ º¹À⼺À» ÀÌÇØÇÏ´Â °ÍÀº ÀÌ·¯ÇÑ È¯°æ¿¡¼­ ¼º°øÀ» ¸ñÇ¥·Î ÇÏ´Â Á¶Á÷¿¡¼­ °¡Àå Áß¿äÇÕ´Ï´Ù.

¸ñÂ÷

Àü·«Àû °úÁ¦

  • ¿Ö ¼ºÀåÀÌ ¾î·Á¿öÁö°í Àִ°¡?
  • The Strategic Imperative 8(TM)
  • ȯÀÚ Âü¿© »ê¾÷¿¡ ´ëÇÑ ÁÖ¿ä Àü·«Àû °úÁ¦ÀÇ ¿µÇâ
  • Growth Pipeline Engine(TM)À» °¡¼ÓÇÏ´Â ¼ºÀå ±âȸ

¼ºÀå ±âȸ ºÐ¼®

  • ºÐ¼® ¹üÀ§
  • ¾÷°è ±¸ºÐ : Áö¿ªº°
  • ȯÀÚ Âü¿©¶õ?
  • ÁÖ¿ä °æÀï¾÷ü
  • ¼ºÀå ÁöÇ¥
  • À¯Åë ä³Î
  • ÀÇ·á ¼­ºñ½º¿¡¼­ PEÀÇ ÀÌÇØ °ü°èÀÚ
  • Care ContinuumÀÇ PE ¿ëµµ Åø
  • PE Ç÷§Æû-¸ð¹ü »ç·Ê
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • PEÀÇ ±¸Á¶Àû Ư¼º-°úÁ¦ ¹× ÃËÁø¿äÀÎ
  • ¿¹ÃøÀÇ ÀüÁ¦Á¶°Ç
  • ¼öÀÍ ¿¹Ãø
  • ¼öÀÍ ¿¹Ãø : Áö¿ªº°
  • ¼öÀÍ ¿¹Ãø ºÐ¼®-ºñÁî´Ï½º ¸ðµ¨ µ¿Çâ
  • °¡°Ý µ¿Çâ ¹× ¿¹Ãø ºÐ¼®
  • °æÀï ȯ°æ
  • ¼öÀÍ Á¡À¯À²
  • ¼öÀÍ Á¡À¯À² ºÐ¼®
  • PE¿¡ À־ÀÇ µð½º¶óÇÁƼºê ±â¼ú

¼ºÀå ±âȸ ºÐ¼®-ºÏ¹Ì

  • ¼ºÀå ÁöÇ¥
  • ¼öÀÍ ¿¹Ãø
  • ¿¹Ãø ºÐ¼®
  • ¹Ì±¹ ȯÀÚ¿¡ ÀÇÇÑ º´¿ø Äɾ ´ëÇÑ ½ÃÁ¡

¼ºÀå ±âȸ ºÐ¼®-¼­À¯·´

  • ¼ºÀå ÁöÇ¥
  • ¼öÀÍ ¿¹Ãø
  • ¿¹Ãø ºÐ¼®
  • À¯·´ Á¾¾ç¿¡¼­ PRO(ȯÀÚº¸°í °á°ú) ÁöÇ¥ »ç¿ë

¼ºÀå ±âȸ ºÐ¼®-¾Æ½Ã¾ÆÅÂÆò¾ç

  • ¼ºÀå ÁöÇ¥-¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¼öÀÍ ¿¹Ãø
  • ¿¹Ãø ºÐ¼®

¼ºÀå ±âȸ

  • ¼ºÀå ±âȸ 1-°¡Ä¡ ±â¹Ý Äɾî
  • ¼ºÀå ±âȸ 2-Á¤½Å °Ç°­ ¹× ºñÇìÀ̺ñ¾î °Ç°­
  • ¼ºÀå ±âȸ 3-µðÁöÅÐ ¾à±¹
  • ¼ºÀå ±âȸ 4-ÄɾîÀÇ ÀÌÇà

´ÙÀ½ ´Ü°è

AJY 24.06.20

Competitive Strategies to Seize Growth Opportunities

The global patient engagement industry is undergoing substantial expansion. The increasing emphasis on patient-centric healthcare, widespread adoption of digital health solutions, and higher demand for enhanced healthcare outcomes are fueling this industry's growth.

This comprehensive Frost & Sullivan analysis provides an in-depth look at this dynamic sector, offering insights that extend to 2028. It delves into the competitive landscapes, growth strategies, and economic contexts across North America, Europe, and Asia-Pacific. This report excludes the life sciences and B2C PE markets as well as the hardware component of the platforms, such as medical devices and wearables.

This analysis also determines top growth opportunities, disruptive technologies, regional trends, and business model analyses. This thorough examination equips healthcare stakeholders with the knowledge needed to navigate the industry's evolving landscape effectively. As the healthcare industry continues its transformation toward patient-centered care and digital innovation, understanding the intricacies of the patient engagement market becomes paramount for organizations that seek to thrive in this environment.

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on the Patient Engagement Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

  • Scope of Analysis
  • Industry Segmentation by Geography
  • What is Patient Engagement?
  • Key Competitors
  • Growth Metrics
  • Distribution Channels
  • PE Stakeholders in Healthcare Services
  • PE Application Tools across the Care Continuum
  • PE Platforms-Best Practices
  • Growth Drivers
  • Growth Restraints
  • PE Structural Attributes-Challenges and Facilitators
  • Forecast Assumptions
  • Revenue Forecast
  • Revenue Forecast by Region
  • Revenue Forecast Analysis-Business Model Trends
  • Pricing Trends and Forecast Analysis
  • Competitive Environment
  • Revenue Share
  • Revenue Share Analysis
  • Disruptive Technologies in PE

Growth Opportunity Analysis-North America

  • Growth Metrics
  • Revenue Forecast
  • Forecast Analysis
  • US Patients' Perspectives on Hospital Care

Growth Opportunity Analysis-Western Europe

  • Growth Metrics
  • Revenue Forecast
  • Forecast Analysis
  • The Use of Patient-reported Outcome Measures in European Oncology

Growth Opportunity Analysis-Asia-Pacific

  • Growth Metrics-Asia Pacific
  • Revenue Forecast
  • Forecast Analysis

Growth Opportunity Universe

  • Growth Opportunity 1-Value-based Care
  • Growth Opportunity 2-Mental and Behavioral Health
  • Growth Opportunity 3-Digital Pharmacy
  • Growth Opportunity 4-Care Transition

Next Steps

  • Your Next Steps
  • Why Frost, Why Now?
  • List of Exhibits
  • Legal Disclaimer
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦